Magnifying LeNS Archives - Page 5 of 7

Considering Caregivers: The Lung Cancer Registry’s Newest Initiative

Bethany Johnson (GO2 for Lung Cancer)2022-04-28T11:55:54-05:00April 28th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Authors: John Wells, MBA, Senior Specialist, Lung Cancer Registry; Jamie L. Studts, PhD, Professor of Medical Oncology and Scientific Director of Behavioral Oncology, University of Colorado School of Medicine; GO2 for Lung Cancer Scientific Leadership Board Member; International Caregiver [...]

0

New and Improved Lung Cancer Registry

Bethany Johnson (GO2 for Lung Cancer)2022-02-23T10:56:16-06:00February 23rd, 2022|Hot Topics, Magnifying LeNS, News, Newsletter Articles, Science and Research|

First and Only Global Lung Cancer Registry Through its Lung Cancer Registry, GO2 for Lung Cancer securely gathers information from lung cancer patients across the globe - providing researchers with rich data from which to identify trends that can [...]

2

Small Cell Lung Cancer Initiative 2021 Recap and Future Directions

Sarah Wilson2023-09-20T12:45:40-05:00January 27th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research, Small Cell Lung Cancer|

Authors: Amy Kampschroeder MA, OTR/L, CHES, Manager, Patient Outreach and Special Initiatives and Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program In 2021, one of GO2 for Lung Cancer’s priorities continued to be bringing lung cancer education and empowerment to patients to help [...]

4

Navigating Biomarker Testing Issues

Sarah Wilson2022-01-27T15:58:28-06:00January 27th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Author: Andrew Ciupek, PhD, Senior Manager of Clinical Research Due to the increasing number of approved targeted therapies for the treatment of lung cancer, clinical guidelines recommend that every patient receive comprehensive biomarker testing. Despite the importance of comprehensive [...]

0

FDA Approvals: New Treatment Landscape in 2022

Sarah Wilson2022-01-27T16:03:53-06:00January 27th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Author: Daniel A. Saez, MSc, Manager of LungMATCH Navigation Program Despite 2021 being another challenging year, we saw treatment options for lung cancer increase by leaps and bounds. In 2021 the treatment landscape for lung cancer evolved to provide breakthrough treatment [...]

0

Identification of Chemoradiation Response Mediators in Non‐Small Cell Lung Cancer via Circulating Tumor DNA Analysis

Sarah Wilson2022-01-28T07:48:31-06:00January 27th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Author: Everett Moding, MD, PhD, Assistant Professor Department of Radiation Oncology, Stanford University School of Medicine A combination of chemotherapy and radiation therapy (chemoradiation therapy) is the backbone of treatment for non-small cell lung cancer (NSCLC) that has spread [...]

0

Clinical Trials FAQ

Bethany Johnson (GO2 for Lung Cancer)2022-01-20T12:42:44-06:00January 20th, 2022|Magnifying LeNS, Science and Research|

By Daniel A. Saez, M.Sc., Treatment and Trials Navigator, GO2 for Lung Cancer Patients often hear the words clinical trial and don’t know what to expect or sometimes even what a clinical trial is. GO2 for Lung Cancer has [...]

2

Treatments and Other Advances in Early-Stage Non-Small Cell Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2021-10-28T15:07:20-05:00October 28th, 2021|Magnifying LeNS, Newsletter Articles, Science and Research|

Author: Rashmi Acharya, MS, Science and Research Specialist, GO2 for Lung Cancer The 2021 World Conference on Lung Cancer (WCLC) had multiple researchers presenting their findings on broad areas of research in early-stage lung cancer. These presentations bring highly [...]

0

Moving the Needle in Small Cell Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2023-09-20T12:45:56-05:00October 28th, 2021|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research, Small Cell Lung Cancer|

Author: Jennifer C. King, PhD, Chief Scientific Officer, GO2 for Lung Cancer The World Conference on Lung Cancer features research on all types of thoracic cancers—and small cell lung cancer is no exception. There were many talks on new [...]

2

GO2 In Action: Our Involvement in the 2021 World Conference on Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2021-10-28T15:02:45-05:00October 28th, 2021|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Author: Daniel A. Saez, MSc, Treatment and Trials Navigator, GO2 for Lung Cancer This month, the GO2 for Lung Cancer team virtually attended IASLC’s 2021 World Conference on Lung Cancer. Our science and research team provided strong representation for [...]

0